Brightspring Health Services vs Quest Diagnostics
Brightspring Health Services is the larger business, with $12.91bn of revenue in fiscal 2025 against $11.04bn for Quest Diagnostics (1.2 times as much). Brightspring Health Services grew faster (28.2% against 11.8%). Quest Diagnostics kept more of each dollar of sales as profit: a net margin of 9.0% against 1.5%.
| Latest fiscal year | Brightspring Health ServicesBTSG, 2025 | Quest DiagnosticsDGX, 2025 |
|---|---|---|
| Revenue | $12.91bn | $11.04bn |
| Revenue growth | 28.2% | 11.8% |
| Net income | $191m | $992m |
| Operating margin | 2.3% | — |
| Net margin | 1.5% | 9.0% |
| Return on equity | 10.8% | 14.2% |
| Free cash flow | $395m | $1.36bn |
| Cash | $88.4m | $420m |
| Total debt | $2.57bn | $5.67bn |
| Debt to equity | 137.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | 1.3% |
| Share buybacks | $43.2m | $450m |
| Employees | 23,500 | 57,000 |
| Market value | $13.79bn | $27.47bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | — | 70 (Strong) |
| Insider trades, 12 months | 0 buys, 9 sales | 0 buys, 29 sales |